| Douglas James Weaver, | |
|
5841 S Maryland Ave # Mc3079, Chicago, IL 60637-1443 | |
| (773) 834-3531 | |
| Not Available |
| Full Name | Douglas James Weaver |
|---|---|
| Gender | Male |
| Speciality | Orthopaedic Surgery |
| Location | 5841 S Maryland Ave # Mc3079, Chicago, Illinois |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1124600010 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207X00000X | Orthopaedic Surgery | 125.077477 (Illinois) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Douglas James Weaver, 180 Harvester Dr Ste 110, Burr Ridge, IL 60527-6686 Ph: () - | Douglas James Weaver, 5841 S Maryland Ave # Mc3079, Chicago, IL 60637-1443 Ph: (773) 834-3531 |
News Archive
University of Granada researchers have designed a guideline for physicians and patients on the Androgen Insensitivity Syndrome (AIS), a rare disease that makes the subject develop reverse sex, which occurs when a subject looks like a woman but has male genes.
Merck (NYSE: MRK), known as MSD outside the United States and Canada, announced today that the U.S. Food and Drug Administration has designated lambrolizumab (MK-3475) as a Breakthrough Therapy for the treatment of patients with advanced melanoma.
A fun park has been forced to close after more than 700 people, mostly children and teenagers, became sick with a gastrointestinal illness.
Nanoparticles, extremely tiny particles measured in billionths of a meter, are increasingly everywhere, and especially in biomedical products. Their toxicity has been researched in general terms, but now a team of Israeli scientists has for the first time found that exposure nanoparticles (NPs) of silicon dioxide (SiO2) can play a major role in the development of cardiovascular diseases when the NP cross tissue and cellular barriers and also find their way into the circulatory system.
KAI Pharmaceuticals, Inc., a privately held drug discovery and development company, today announced the Company has completed enrollment in a Phase 1 study of KAI-4169, a novel pharmaceutical agent for the treatment of secondary hyperparathyroidism, which is a frequent complication of end stage renal disease.
› Verified 9 days ago
Dr. Yi-loong Colin Woon, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 1740 W Taylor St, Chicago, IL 60612 Phone: 866-600-2273 | |
Dr. Vehniah Kristin Tjong, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 259 E Erie St, 13th Floor, Chicago, IL 60611 Phone: 312-695-6800 | |
David R Guelich, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 3000 Halsted Street, Suite 525, Chicago, IL 60657 Phone: 773-443-3130 | |
Dr. Daniel A Ivankovich, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 1044 N Francisco Ave Ste 203, Chicago, IL 60622 Phone: 312-527-6500 Fax: 800-281-6952 | |
Dr. Michael R Treister, M.D. Orthopedic Surgery Medicare: Not Enrolled in Medicare Practice Location: 1431 N Western Ave, Chicago, IL 60622 Phone: 312-633-5866 Fax: 312-633-5867 | |
Dr. Adam Isaac Edelstein, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 259 E Erie St Ste 13-205, Chicago, IL 60611 Phone: 312-695-8143 Fax: 312-695-4075 | |
Dr. Ari J Kaz, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 2923 N California Ave, Suite 300, Chicago, IL 60618 Phone: 773-777-9900 Fax: 773-777-5927 |